Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boxed Warning For Antipsychotics First Public Use Of FDA Labeling Authority

Executive Summary

FDA put its new labeling authority under the FDA Amendments Act on public display June 16 by directing makers of conventional antipsychotics to add to their drugs' prescribing information a boxed warning about use in elderly patients with dementia
Advertisement

Related Content

FDAAA Safety Labeling Powers Are Invoked Selectively But Leave Drugmakers Little Room To Maneuver
FDAAA Safety Labeling Powers Are Invoked Selectively But Leave Drugmakers Little Room To Maneuver
Atypical antispychotics class warning
Atypical antispychotics class warning
Fluoroquinolone REMS Will Survey Patients, Doctors on Understanding of Risk
Fluoroquinolone REMS Will Survey Patients, Doctors on Understanding of Risk
ANDA Reviews: Inspector General Weighs In, But Progress Depends On Congress
Antipsychotics Commonly Used Off-Label By Dementia Patients, AHRQ Finds
Antipsychotic Boxed Warning Will Caution Against Off-Label Use In Dementia
Antipsychotic Boxed Warning Will Caution Against Off-Label Use In Dementia
Advertisement
UsernamePublicRestriction

Register

PS049776

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel